SELLAS Life Sciences Grou... (SLS)
undefined
undefined%
At close: undefined
0.86
-1.64%
After-hours Dec 13, 2024, 07:59 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06
Revenue - 1.00M 7.60M 1.90M - - - - - 9.32M 2.49M 2.04M - - - - - -
Cost of Revenue - 100.00K 200.00K - - - - 3.00K 355.00K 1.40M 520.00K - 20.79M - - - 11.41M -
Gross Profit - 900.00K 7.40M 1.90M - - - -3.00K -355.00K 7.92M 1.97M 2.04M -20.79M - - - -11.41M -
Operating Income -37.87M -41.95M -25.29M -16.98M -20.04M -31.09M -23.04M -31.87M -34.22M -52.22M -33.84M -21.20M -20.79M -16.63M -17.52M -14.55M -11.41M -2.40M
Interest Income 525.00K 317.00K 6.00K 26.00K 118.00K - - - - - - - - - - 180.00K 448.00K -
Pretax Income -37.34M -41.30M -20.94M -16.77M -19.37M -29.05M -23.50M -10.86M -38.59M -36.61M -75.63M -34.38M -11.48M -11.99M -18.39M -14.37M -10.96M -2.40M
Net Income -37.34M -40.65M -20.70M -16.76M -19.29M -27.67M -23.75M -23.55M -63.90M -36.61M -76.68M -34.97M -11.48M -11.99M -18.39M -14.37M -10.99M -2.40M
Selling & General & Admin 13.86M 12.58M 11.32M 9.60M 9.92M 12.77M 15.09M 12.01M 10.61M 31.34M 14.60M 6.58M 9.25M 8.75M 8.63M 7.50M 4.67M 633.00K
Research & Development 24.01M 30.27M 21.37M 9.28M 7.29M 18.32M 6.07M 19.86M 23.61M 28.35M 21.08M 14.61M 11.54M 7.87M 8.89M 7.05M 6.75M 1.30M
Other Expenses - 10.00M 5.70M - - -3.03M - - 509.00K 170.00K 37.00K -13.18M 9.25M - - 7.50M - -
Operating Expenses 37.87M 42.85M 32.69M 18.88M 17.21M 31.09M 21.16M 31.87M 34.22M 60.14M 35.81M 21.20M 20.79M 16.63M 17.52M 14.55M 11.41M 2.40M
Interest Expense - - - - 118.00K 266.00K 462.00K 3.51M 760.00K 1.11M 807.00K 33.00K - 5.00K -5.00K - - -
Selling & Marketing Expenses - - - - - - - - - - - - 2.39M - - 2.63M 931.00K -
Cost & Expenses 37.87M 42.95M 32.89M 18.88M 17.21M 31.09M 21.16M 31.87M 34.22M 61.54M 36.33M 21.20M 20.79M 16.63M 17.52M 14.55M 11.41M 2.40M
Income Tax - -649.00K -237.00K -17.00K -81.00K -1.38M 253.00K 243.00K 365.00K -15.45M 1.05M -1.05M -9.30M -4.63M 867.00K - 25.00K -
Shares Outstanding (Basic) 27.78M 19.40M 15.48M 7.98M 2.56M 261.54K 46.81K 6.64K 5.17K 3.98K 3.01K 2.08K 1.21K 612.00 540.00 458.00 422.00 420.00
Shares Outstanding (Diluted) 27.78M 19.40M 15.48M 7.98M 2.56M 261.54K 46.81K 6.64K 5.17K 3.98K 3.01K 2.08K 1.21K 612.00 540.00 458.00 422.00 420.00
EPS (Basic) -1.34 -2.1 -1.34 -2.1 -7.54 -105.8 -507.49 -3.55K -12.35K -9.20K -25.51K -16.80K -9.48K -19.60K -34.05K -31.38K -26.04K -5.73K
EPS (Diluted) -1.34 -2.1 -1.34 -2.1 -7.54 -105.8 -507.49 -3.55K -12.35K -9.20K -25.51K -16.80K -9.48K -19.60K -34.05K -31.38K -26.04K -5.73K
EBITDA 529.00K -31.95M -19.66M -16.40M 668.00K - -23.04M -15.98M -37.48M -36.61M 7.63M -34.38M -11.32M -11.82M -18.22M -14.24M -10.93M -2.40M
Depreciation & Amortization 37.87M 457.00K 1.27M 377.00K 17.21M 22.04M 3.00K 3.00K 355.00K 440.00K 452.00K 49.00K 163.00K 172.00K 162.00K 131.00K 36.00K -